Wynne Weston- Davis

Wynne Weston- Davis

Company: Akari Therapeutics

Job title: Medical Director


Wynne qualified in medicine at the University of London and later gained the Fellowship of the Royal College of Surgeons of England. He practiced as a general and colorectal surgeon for ten years before moving into clinical research. After working in the cardiovascular, antimicrobial and wound healing areas for Bristol Myers Squibb, he led preclinical and clinical research for two biotechnology companies before being appointed in 2015 as Medical Director of Akari Therapeutics, a New York and London based company whose complement C5 and LTB4 inhibitor, nomacopan, is currently in late-phase clinical development. He is a member of the European Complement Network and the International Complement Society. 

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.